Pharmatek to Present at the 9th Annual Clinical Suply Forum on Early-Phase Drug Product Strategies for Oral Dosage Forms
SAN DIEGO, Calif. – January 31, 2013- Brent Moody, technical sales representative, Pharmatek, will present at the 9th Clinical Supply Forum in Durham, NC on February 7, 2013. Mr. Moody’s presenation, entitled, “Early-Phase Drug Product Strategies for Oral Dosage Forms” will provide insight and understanding into the reasoning behind development decisions in the early stages of the drug development cycle. He will compare and contrast common Phase I dosing options, such powder-in-bottle (PIB), powder-in-capsule (PIC) and formulated dosage unites, as well as identify early development considerations when defining Chemistry, Manufacturing and Control (CMC) strategies of a trial drug and examine common questions regarding Phase I formulation development.
The Clinical Supply Forum will feature clinical supply chain topics spanning product stability, QP release and dosage form development and cGMP supply of clinical trial material. The goal of the Forum is to provide a setting for the discussion of best practices for the delivery of regulatory compliant and cost effective clincal supplies. The cost to attend his one day event is $145.
Pharmatek has more than 14 years of experience working with pharmaceutical companies to advance their early stage drug candidates by focusing on efficient dosage form development and cGMP manufacturing solutions. The company’s expertise has helped deliver effective treatments, while reducing overall project cost and time-to-clinic with a high level of quality and customer service.
To schedule an interview with the above mentioned presenter, or to obtain a copy of the presentation after the event please contact Kimberly Scholz at firstname.lastname@example.org.
Visit www.Pharmatek.com for more information on Pharmatek’s dosage form development and cGMP manufacturing services.Leave a reply →